Neurokinin receptor antagonists as potential non-hormonal treatments for vasomotor symptoms of menopause
Vasomotor symptoms of menopause (VMS), otherwise known as hot flashes, can significantly impact women’s quality of life. Up to 87% of women report hot flashes during or after their menopause transition, and can last for a median duration of 7.4 years. The current mainstay of treatment and the most e...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2023-06-01
|
| Series: | Therapeutic Advances in Reproductive Health |
| Online Access: | https://doi.org/10.1177/26334941231177611 |